دورية أكاديمية
Implantable cardioverter-defibrillator lead failure and revision following transcutaneous bicaval valve (TricValve®) implantation.
| العنوان: | Implantable cardioverter-defibrillator lead failure and revision following transcutaneous bicaval valve (TricValve®) implantation. |
|---|---|
| المؤلفون: | Plant A; Department of Cardiology, Wellington Regional Hospital, Te Whatu Ora Capital and Coast, Newtown, Wellington, New Zealand., Stewart F; Department of Cardiology, Wellington Regional Hospital, Te Whatu Ora Capital and Coast, Newtown, Wellington, New Zealand., Hooks D; Department of Cardiology, Wellington Regional Hospital, Te Whatu Ora Capital and Coast, Newtown, Wellington, New Zealand. |
| المصدر: | Journal of cardiovascular electrophysiology [J Cardiovasc Electrophysiol] 2024 May; Vol. 35 (5), pp. 1050-1054. Date of Electronic Publication: 2024 Mar 19. |
| نوع المنشور: | Case Reports; Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Blackwell Country of Publication: United States NLM ID: 9010756 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-8167 (Electronic) Linking ISSN: 10453873 NLM ISO Abbreviation: J Cardiovasc Electrophysiol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Malden, MA : Blackwell Original Publication: Mt. Kisco, N.Y. : Futura Pub., c1990- |
| مواضيع طبية MeSH: | Defibrillators, Implantable* , Equipment Failure* , Tricuspid Valve Insufficiency*/surgery , Tricuspid Valve Insufficiency*/physiopathology , Tricuspid Valve Insufficiency*/diagnostic imaging, Humans ; Heart Valve Prosthesis ; Heart Valve Prosthesis Implantation/instrumentation ; Heart Valve Prosthesis Implantation/adverse effects ; Male ; Aged ; Treatment Outcome ; Reoperation ; Prosthesis Design ; Device Removal ; Female ; Electric Countershock/instrumentation ; Electric Countershock/adverse effects |
| مستخلص: | Introduction: Tricuspid regurgitation is associated with significant morbidity and mortality, and occurs at a higher rate in patients with cardiovascular implantable electronic devices. Percutaneous strategies for managing tricuspid regurgitation are evolving, including the development of bicaval valve implantation which has been successfully used in patients with pacing leads. Methods and Results: We present the first documented case of lead failure following TricValve® implantation, a dedicated self-expanding system for bicaval valve implantation, and the first successful lead revision procedure in this setting. Conclusion: The case illustrates important considerations in undertaking percutaneous intervention in patients with cardiovascular implantable electronic devices, and their ongoing management. (© 2024 Wiley Periodicals LLC.) |
| References: | Mutlak D, Aronson D, Lessick J, Reisner SA, Dabbah S, Agmon Y. Functional tricuspid regurgitation in patients with pulmonary hypertension. Chest. 2009;135(1):115‐121. Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021;42(35):3427‐3520. Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long‐term survival. J Am Coll Cardiol. 2004;43(3):405‐409. McCarthy PM, Bhudia SK, Rajeswaran J, et al. Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg. 2004;127(3):674‐685. Lurz P, von Bardeleben RS, Weber M, et al. Transcatheter edge‐to‐edge repair for treatment of tricuspid regurgitation. J Am Coll Cardiol. 2021;77(3):229‐239. Hahn RT, Kodali S, Fam N, et al. Early multinational experience of transcatheter tricuspid valve replacement for treating severe tricuspid regurgitation. JACC Cardiovasc Interv. 2020;13(21):2482‐2493. Estévez‐Loureiro R, Sánchez‐Recalde A, Amat‐Santos IJ, et al. 6‐Month outcomes of the TricValve system in patients with tricuspid regurgitation. JACC Cardiovasc Interv. 2022;15(13):1366‐1377. Lauten A, Doenst T, Hamadanchi A, Franz M, Figulla HR. Percutaneous bicaval valve implantation for transcatheter treatment of tricuspid regurgitation: clinical observations and 12‐month follow‐up. Circ Cardiovasc Interv. 2014;7(2):268‐272. Lauten A, Figulla HR, Unbehaun A, et al. Interventional treatment of severe tricuspid regurgitation: early clinical experience in a multicenter, observational, first‐in‐man study. Circ Cardiovasc Interv. 2018;11(2):1‐9. Cespón‐Fernández M, Teijeira‐Fernández E, Estévez‐Loureiro R, De miguel‐Castro AA, García‐Campo E, Íñiguez‐Romo A. Pacemaker lead implantation in a patient with transcatheter bicaval prosthesis. Europace. 2021;23(4):564. Spaccarotella CAM, Sorrentino S, Mongiardo A, et al. Acute expansion of nitinol‐based self‐expandable device in patients undergoing transfemoral aortic valve implantation. J Cardiovasc Med. 2023;24(5):308‐312. |
| فهرسة مساهمة: | Keywords: cardiovascular implantable electronic devices; implantable cardioverter defibrillator; lead failure; structural heart intervention; tricuspid regurgitation |
| تواريخ الأحداث: | Date Created: 20240319 Date Completed: 20240425 Latest Revision: 20240425 |
| رمز التحديث: | 20240425 |
| DOI: | 10.1111/jce.16249 |
| PMID: | 38501328 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1540-8167 |
|---|---|
| DOI: | 10.1111/jce.16249 |